Showing 121-130 of 821 results for "".
Find Your Niche
https://practicaldermatology.com/topics/practice-management/find-your-niche/19078/Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions offer tips for setting yourself and your practice apart. Develop your specialization, build a reputation, and you won't have to compete on price or rely on marketing gimmicks.Staying Compliant
https://practicaldermatology.com/topics/practice-management/staying-compliant/19081/Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions offer straight talk on compliance, suggesting that practice's turn to trusted experts who can focus on staying within the requirements of the law.Long-Term Bimzelx Data Presented
https://practicaldermatology.com/videos/dermwire-tv/long-term-bimzelx-data-presented/35563/In this week's DermwireTV, new long-term data is presented for Bimzelx (bimekizumab-bkzx) for two indications; an analysis examines the correlation between proximity to tanning facilities and melanoma incidence; and in our C-Suite Chats feature, we hear from the Founder and CEO of Joya Health.Building an Inflammatory Clinic
https://practicaldermatology.com/videos/pa-perspectives/building-inflammatory-clinic/26436/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses how to build an inflammatory clinic as an advanced practice practitioner (APP). Andrew also discusses what factors APPs should consider when prescribing mediSave Money; Don't Sacrifice Staff
https://practicaldermatology.com/topics/practice-management/save-money-don-t-sacrifice-staff/19079/Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions warn against the common mistake of cutting back on or not investing in staff. There are better ways to save money without hurting your practice.Leading Dermatologists Summarize Maui Derm Presentations
https://practicaldermatology.com/videos/dermwire-tv/leading-dermatologists-summarize-maui-derm-presentations/32839/In this week's DermwireTV, top thought leaders provide a summary of their presentations at Maui Derm; a new analysis examines a link between hidradenitis suppurativa genetics and coronary artery disease risk; and the president of Castle Biosciences joins us for this week's C-Suite Chats fJoin the (Buying) Club
https://practicaldermatology.com/topics/practice-management/join-the-buying-club/18547/Every practice must buy a certain amount of supplies month to month. There's no getting around it. But you can save on those purchases. Among your options, consider a buying club. Jay A. Shorr, BA, MBM-C, CAC I-IX explains.Is this the Golden Age of Hair Loss Treatment?
https://practicaldermatology.com/topics/hair-nails/is-this-the-golden-age-of-hair-loss-treatment/24036/A perfect storm of many new, unrelated scientific developments also has the potential to fundamentally reshape the way we think about a disease or disease group. Dr. Peter C. Friedman believes many recent breakthroughs have profoundly changed how general dermatologists can manage patients with hairISDPA: Dr. Lio on Alternative and Innovative Approaches
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-lio-alternative-and-innovative-approaches/27066/Practical Dermatology Editorial Board member Peter Lio, MD, discusses the presentation that he and Tracee Blackburn, PA-C, gave about alternative and innovative approaches in dermatology, as well as the importance of educational engagement between physician assistants and dermatologists, at the IlliBiologics Preferred after MACE in PsO, Plus More
https://practicaldermatology.com/series/dermwire-tv/biologics-preferred-after-mace-in-pso-plus-more/37882/In this edition of DermwireTV, new research shows biologic use use after MACE is persistent, signaling strong patient preference; a new study shows that early stress may raise lifelong psoriasis risk; and a new C-Suite Chat highlights a new antibody showing promise in treating atopic dermatitis